인공지능 진단 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 구성요소별, 진단 유형별, 지역별, 경쟁별(2020-2030년)

The Global Artificial Intelligence Diagnostics Market, valued at USD 2.10 Billion in 2024, is projected to experience a CAGR of 7.02% to reach USD 3.16 Billion by 2030. The Global Artificial Intelligence Diagnostics Market encompasses the application of AI algorithms and machine learning techniques to analyze diverse medical data, including imaging, genomic sequences, and patient records, for enhanced disease detection, diagnosis, and prognosis. Market expansion is primarily supported by the increasing global prevalence of chronic diseases, the critical demand for early and accurate disease identification, and the necessity for improved diagnostic efficiency within healthcare systems.

Key Market Drivers

Advancements in artificial intelligence technologies represent a primary catalyst for growth within the global artificial intelligence diagnostics market. Continuous innovation in machine learning algorithms, deep learning models, and computational processing power has significantly enhanced the capability of AI systems to interpret complex medical data with greater precision. For example, according to "Advancements in Artificial Intelligence for Medical Computer-Aided Diagnosis," June 2024, an optimized XGBoost model achieved 98.50% accuracy in enhancing diagnostic accuracy for heart disease, demonstrating the tangible improvements these technologies bring to diagnostic precision.

Key Market Challenges

The complex and continuously evolving regulatory frameworks governing AI-powered diagnostic solutions present a significant impediment to the growth of the Global Artificial Intelligence Diagnostics Market. This environment mandates rigorous validation and extensive approval processes, which directly prolong product development timelines and substantially elevate the costs associated with market entry for new technologies. Such demands necessitate considerable investment in regulatory compliance and specialized expertise, forming a critical barrier for manufacturers.

Key Market Trends

The integration of AI with wearable devices and continuous monitoring is significantly expanding diagnostic capabilities beyond traditional clinical environments. These AI-powered wearables continuously collect vital signs and physiological data, enabling real-time assessment and early anomaly detection for proactive health management. The growing acceptance of AI in clinical practice is evident as the American Medical Association reported physician usage of AI surged from 38% in 2023 to 66% in 2024, indicating increasing trust in these tools.

Key Market Players

• Vuno Inc.
• CHC Healthcare Group
• AIDoc Medical Ltd.
• Imbio
• AliveCor, Inc.
• Digital Diagnostics Inc.
• Retina AI, Inc.
• Canon Medical Systems Corp.
• Healthy.io Ltd
• Milliman, Inc.

Report Scope:

In this report, the Global Artificial Intelligence Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Intelligence Diagnostics Market, By Component:

• Software
• Hardware
• Services

Artificial Intelligence Diagnostics Market, By Diagnosis Type:

• Cardiology
• Oncology
• Pathology
• Radiology
• Neurology
• Others

Artificial Intelligence Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Artificial Intelligence Diagnostics Market.

Available Customizations:

Global Artificial Intelligence Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artificial Intelligence Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Software, Hardware, Services)
  • 5.2.2. By Diagnosis Type (Cardiology, Oncology, Pathology, Radiology, Neurology, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Artificial Intelligence Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Diagnosis Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Artificial Intelligence Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Diagnosis Type
  • 6.3.2. Canada Artificial Intelligence Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Diagnosis Type
  • 6.3.3. Mexico Artificial Intelligence Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Diagnosis Type

7. Europe Artificial Intelligence Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Diagnosis Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Artificial Intelligence Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Diagnosis Type
  • 7.3.2. France Artificial Intelligence Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Diagnosis Type
  • 7.3.3. United Kingdom Artificial Intelligence Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Diagnosis Type
  • 7.3.4. Italy Artificial Intelligence Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Diagnosis Type
  • 7.3.5. Spain Artificial Intelligence Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Diagnosis Type

8. Asia Pacific Artificial Intelligence Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Diagnosis Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Artificial Intelligence Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Diagnosis Type
  • 8.3.2. India Artificial Intelligence Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Diagnosis Type
  • 8.3.3. Japan Artificial Intelligence Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Diagnosis Type
  • 8.3.4. South Korea Artificial Intelligence Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Diagnosis Type
  • 8.3.5. Australia Artificial Intelligence Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Diagnosis Type

9. Middle East & Africa Artificial Intelligence Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Diagnosis Type
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Artificial Intelligence Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Diagnosis Type
  • 9.3.2. UAE Artificial Intelligence Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Diagnosis Type
  • 9.3.3. South Africa Artificial Intelligence Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Diagnosis Type

10. South America Artificial Intelligence Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Diagnosis Type
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Artificial Intelligence Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Diagnosis Type
  • 10.3.2. Colombia Artificial Intelligence Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Diagnosis Type
  • 10.3.3. Argentina Artificial Intelligence Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Diagnosis Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Artificial Intelligence Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Vuno Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. CHC Healthcare Group
• 15.3. AIDoc Medical Ltd.
• 15.4. Imbio
• 15.5. AliveCor, Inc.
• 15.6. Digital Diagnostics Inc.
• 15.7. Retina AI, Inc.
• 15.8. Canon Medical Systems Corp.
• 15.9. Healthy.io Ltd
• 15.10. Milliman, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer